Navigating the Current Landscape of Non-Clear Cell Renal Cell Carcinoma: A Review of the Literature

被引：10
作者：
John, Alexius [1 ,2 ]
Spain, Lavinia [2 ]
Hamid, Anis A. [1 ,2 ,3 ,4 ]
机构：
[1] Eastern Hlth, Dept Med Oncol, Melbourne, Vic 3128, Australia
[2] Peter MacCallum Canc Ctr, Dept Med Oncol, Melbourne, Vic 3000, Australia
[3] Monash Univ, Eastern Hlth Clin Sch, Melbourne, Vic 3128, Australia
[4] Univ Melbourne, Dept Surg, Melbourne, Vic 3010, Australia
来源：
CURRENT ONCOLOGY | 2023年 / 30卷 / 01期
关键词：
non-clear cell; renal cell carcinoma; papillary; hereditary leiomyomatosis and renal cell cancer; chromophobe; medullary; collecting duct; COMPREHENSIVE MOLECULAR CHARACTERIZATION; OPEN-LABEL; PHASE-II; SUNITINIB; CABOZANTINIB; EPIDEMIOLOGY; MULTICENTER; MONOTHERAPY; EXPRESSION; CRIZOTINIB;
D O I：
10.3390/curroncol30010070
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Non-clear cell renal cell carcinoma (nccRCC) is an entity comprised of a heterogeneous constellation of RCC subtypes. Genomic profiling has broadened our understanding of molecular pathogenic mechanisms unique to individual nccRCC subtypes. To date, clinical trials evaluating the use of immunotherapies and targeted therapies have predominantly been conducted in patients with clear cell histology. A comprehensive review of the literature has been undertaken in order to describe molecular pathogenic mechanisms pertaining to each nccRCC subtype, and concisely summarise findings from therapeutic trials conducted in the nccRCC space.
引用
收藏
页码：923 / 937
页数：15
相关论文
共 88 条
  • [71] Association between PD-L1 Expression and the Prognosis and Clinicopathologic Features of Renal Cell Carcinoma: A Systematic Review and Meta-Analysis
    Shen, Maolei
    Chen, Guang
    Xie, Qiang
    Li, Xin
    Xu, Hao
    Wang, Hui
    Zhao, Shankun
    [J]. UROLOGIA INTERNATIONALIS, 2020, 104 (7-8) : 533 - 541
  • [72] Shetty A, 2014, OCHSNER J, V14, P270
  • [73] A Review of Papillary Renal Cell Carcinoma and MET Inhibitors
    Smith, Katherine Emilie Rhoades
    Bilen, Mehmet Asim
    [J]. KIDNEY CANCER, 2019, 3 (03) : 151 - 161
  • [74] Srigley JR, 1998, SEMIN DIAGN PATHOL, V15, P54
  • [75] Srinivasan R, 2020, J CLIN ONCOL, V38
  • [76] Collecting duct carcinoma of the kidney: Disease characteristics and treatment outcomes from the National Cancer Database
    Sui, Wilson
    Matulay, Justin T.
    Robins, Dennis J.
    James, Maxwell B.
    Onyeji, Ifeanyi C.
    RoyChoudhury, Arindam
    Wenske, Sven
    DeCastro, Guarionex Joel
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2017, 35 (09) : 540.e13 - 540.e18
  • [77] Krebs-cycle-deficient hereditary cancer syndromes are defined by defects in homologous-recombination DNA repair
    Sulkowski, Parker L.
    Sundaram, Ranjini K.
    Oeck, Sebastian
    Corso, Christopher D.
    Liu, Yanfeng
    Noorbakhsh, Seth
    Niger, Monica
    Boeke, Marta
    Ueno, Daiki
    Kalathil, Aravind Nambiar
    Bao, Xun
    Li, Jing
    Shuch, Brian
    Bindra, Ranjit S.
    Glazer, Peter M.
    [J]. NATURE GENETICS, 2018, 50 (08) : 1086 - +
  • [78] Efficacy and Safety of Nivolumab Plus Ipilimumab versus Sunitinib in First-line Treatment of Patients with Advanced Sarcomatoid Renal Cell Carcinoma
    Tannir, Nizar M.
    Signoretti, Sabina
    Choueiri, Toni K.
    McDermott, David F.
    Motzer, Robert J.
    Flaifel, Abdallah
    Pignon, Jean-Christophe
    Ficial, Miriam
    Frontera, Osvaldo Aren
    George, Saby
    Powles, Thomas
    Donskov, Frede
    Harrison, Michael R.
    Barthelemy, Philippe
    Tykodi, Scott S.
    Kocsis, Judit
    Ravaud, Alain
    Rodriguez-Cid, Jeronimo R.
    Pal, Sumanta K.
    Murad, Andre M.
    Ishii, Yuko
    Saggi, Shruti Shally
    McHenry, M. Brent
    Rini, Brian, I
    [J]. CLINICAL CANCER RESEARCH, 2021, 27 (01) : 78 - 86
  • [79] Everolimus Versus Sunitinib Prospective Evaluation in Metastatic Non-Clear Cell Renal Cell Carcinoma (ESPN): A Randomized Multicenter Phase 2 Trial
    Tannir, Nizar M.
    Jonasch, Eric
    Albiges, Laurence
    Altinmakas, Emre
    Ng, Chaan S.
    Matin, Surena F.
    Wang, Xuemei
    Wang, Xuemei
    Qiao, Wei
    Lim, Zita Dubauskas
    Tamboli, Pheroze
    Rao, Priya
    Sircar, Kanishka
    Karam, Jose A.
    McDermott, David F.
    Wood, Christopher G.
    Choueiri, Toni K.
    [J]. EUROPEAN UROLOGY, 2016, 69 (05) : 866 - 874
  • [80] Insertion-and-deletion-derived tumour-specific neoantigens and the immunogenic phenotype: a pan-cancer analysis
    Turajlic, Samra
    Litchfield, Kevin
    Xu, Hang
    Rosenthal, Rachel
    McGranahan, Nicholas
    Reading, James L.
    Wong, Yien Ning S.
    Rowan, Andrew
    Kanu, Nnennaya
    Al Bakir, Maise
    Chambers, Tim
    Salgado, Roberto
    Savas, Peter
    Loi, Sherene
    Birkbak, Nicolai J.
    Sansregret, Laurent
    Gore, Martin
    Larkin, James
    Quezada, Sergio A.
    Swanton, Charles
    [J]. LANCET ONCOLOGY, 2017, 18 (08) : 1009 - 1021
123456789